Go to Contents
ABOUT US
Company History
Contact Us
PIPELINE
Development Pipeline
BAL0891
SJ-600 Series
Pexa-Vec(JX-594)
JX-900 Series
TECHNOLOGY
GEEV ®
SOLVE ®
Scientific Publications
PARTNERSHIP
Global
Partnership
IR/PR
Publications & News
Financials
IR Inquiries
SillaJen Biotherapeutics
About SillaJen Biotherapeutics
Contact Us
Sillajen Sitemap
ABOUT US
Company History
Contact Us
PIPELINE
Development Pipeline
BAL0891
SJ-600 Series
Pexa-Vec (JX-594)
JX-900 Series
TECHNOLOGY
GEEV ®
SOLVE ®
Scientific Publications
PARTNERSHIP
Global Partnership
IR/PR
Publications & News
Financials
IR Inquiries
SillaJen Biotherapeutics
About SillaJen Biotherapeutics
Contact Us
ENG
|
KOR
ENG
ENG
KOR
Targeting, Attacking, and Eradicating Cancers®
TOP
ABOUT US
ABOUT US
TECHNOLOGY
PIPELINE
PARTNERSHIP
IR/PR
SillaJen Biotherapeutics
Contact Us
Company History
Contact Us
Contact Us
SillaJen Headquarter
SillaJen Head Office
SillaJen Head Office 3rd Floor, 106 Cheonggyecheon-ro, Jung-gu, Seoul (ZIP Code : 04542)
+82 (2) 368-2600
+82 (2) 783-7555
Gwanggyo Office
SillaJen Research Center
37, Poeun-daero 59beon-gil, Suji-gu, Yongin-si, Gyeonggi-do, Republic of Korea
Pharmaceutical Division
Sillajen Pharmaceutical Division
142-10 Saneop-ro 156beon-gil, Gwonseon-gu, Suwon-si, Gyeonggi-do, Republic of Korea 16648
070-4193-0443
Targeting, Attacking, and Eradicating Cancers®
